Syncom Formulations India Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on May 30, 2018, inter alia, to consider and approve the following businesses:
1. To consider & approve the Audited Financial Results of the Company for the Quarter/Year ended March 31, 2018.
2. To take on record the Audit Report submitted by the Auditors for the Financial Results of the Company for the Quarter/Year ended March 31, 2018.
3. To recommend dividend on Equity Shares of Re.1/- each for financial year 2017 -18, if any.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
